Edward Kreider, MD
Infectious Diseases
Accepting new patients
Sees patients age 18 and up
MacGregor Infection Medicine and Travel Program
Penn Medicine Provider
About me
- Assistant Professor of Medicine (Infectious Diseases)
My education and training
- Medical School: University of Pennsylvania School of Medicine
- Residency: Hospital of the University of Pennsylvania
- Fellowship: Hospital of the University of Pennsylvania
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Infectious Disease, 2024
- Internal Medicine, 2021
- Center for Transcriptional Medicine, National
- College of Physicians of Philadelphia, National
- College of Physicians of Philadelphia, Local
- Infectious Diseases and Therapy, Springer Healthcare, National
- Mutter Museum, Local
- Penn CFAR Scholars Program, CFAR Diversity, Equity, and Inclusion Pipeline Initiative, National
- Penn Institute for RNA Innovation, International
- Penn Medicine Program for LGBT Health, Local
Treatments and conditions
Research
Publications
Skelly AN, Gristick HB, Li H, Gavor E, Connell AJ, Kreider EF, Marchitto L, Hogarty MP, Newby ML, Allen JD, Liu W, West AP Jr, Ayyanathan K, Campion MS, Winters K, Gordon CG, Osbaldeston RA, Akeley MJ, Li Y, Singh A, Cruickshank K, Park Y, Zhao C, Li X, Amereh K, Itallie EV, Carey JW, Albertus A, DeLaitsch AT, Keeffe JR, Lituchy MG, Walsh AA, Morris DJ, Habib R, Bibollet-Ruche F, Mishra N, Avillion G, Koranda NS, Plante SJ, Martella CL, Lora J, Wang EJD, Lewis MG, Martin MA, Nussenzweig MC, Seaman MS, Irvine DJ, Wiehe KJ, Haynes BF, Wagh K, Korber BT, Andrabi R, Crispin M, Weissman D, Bjorkman PJ, Hahn BH, Shaw GM. Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design. , Science, 18(392): 2026,6804
Marchitto L, Wagh K, Roark RS, Coleon S, Li H, Skelly AN, Hogarty MP, Habib R, Ding W, Ayyanathan K, Liu W, Sheng Z, Guo Y, Bal J, Smith LM, Sutherland LL, Park Y, Connell AJ, Bibollet-Ruche F, Lewis E, Plante SJ, Akeley MJ, Lora J, Zhao C, Carey JW, Martella CL, Li Y, Campion MS, Lituchy MG, Osbaldeston RA, Gordon CG, Albertus A, Su J, Noguchi C, Tam YK, Barbosa C, Liang B, Amereh K, Li X, Walsh AA, Irvine DJ, Andrabi R, Edwards RJ, Kreider EF, Weissman D, Shapiro L, Kwong PD, Korber BT, Haynes BF, Saunders KO, Hahn BH, Shaw GM. Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies. , Nature: 2026
Skelly AN, Fan C, Keeffe JR, Ökten AB, Gavor E, Newby ML, Allen JD, Kreider EF, Ding W, Osbaldeston RA, Park Y, Connell AJ, Lituchy MG, Bibollet-Ruche F, Radford KM, P West A Jr, Peña-Hernández MA, Cruickshank K, Liu W, Li Y, Albertus A, McWilliams B, Russell RM, Konrath KM, Torres JL, Yuan M, Gao H, Montefiori DC, Saag MS, Goepfert PA, Kulp DW, Ward AB, Wilson IA, Shaw GM, Andrabi R, Crispin M, Weissman D, Wilen CB, Bjorkman PJ, Hahn BH. mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model. , Proc Natl Acad Sci U S A, 123(24): 2026
Ökten AB, Filler RB, Kung JL, Fang Z, McWilliams BC, Muscat-Rivera JE, Kegel MS, Olivi Gomes IM, Mankowski MC, Skelly AN, Melamed JR, Nice TJ, Lee S, Baldridge MT, Smith TJ, Wobus CE, Eisenbarth SC, Williams A, Serebryannyy LA, Douek DC, Weissman D, Chen S, Kreider EF, Craft JE, Wilen CB. IgA is necessary and sufficient to prevent norovirus infection in mice. , Sci Transl Med., 18(855): 2026
Corrigan AR, Ngiow SF, Statzu M, Albertus A, Pampena MB, Nordin JML, Carro SD, Harper J, Stammen RL, Wood J, Ni H, Su J, Hajialyani M, Shuvaev VV, Alcalde V, Ali MA, Hamilton JT, Ramalingam R, Wu VH, Paiardini M, Weissman D, Wherry EJ, Kreider EF, Betts MR. In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs , Sci Immunol, 11: 2026,eaec3436
Skelly AN, Gristick HB, Li H, Gavor E, Connell AJ, Kreider EF, Marchitto L, Hogarty MP, Newby ML, Allen JD, Liu W, West AP Jr, Ayyanathan K, Campion MS, Winters K, Gordon CG, Osbaldeston RA, Akeley MJ, Lewis E, Li Y, Singh A, Cruickshank K, Park Y, Zhao C, Li X, Amereh K, Van Itallie E, Carey JW, Albertus A, DeLaitsch AT, Keeffe JR, Lituchy MG, Walsh AA, Morris DJ, Habib R, Bibollet-Ruche F, Mishra N, Avillion G, Koranda NS, Plante SJ, Martella CL, Lora J, Wang EJD, Lewis MG, Martin MA, Nussenzweig MC, Seaman MS, Irvine DJ, Wiehe KJ, Haynes BF, Wagh K, Korber B, Andrabi R, Crispin M, Weissman D, Bjorkman PJ, Hahn BH, Shaw GM. Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design , Science: 2026
Ladines-Lim JB, Yang WT, Tebas P, O'Donnell J, Koenig H, Kreider E, Dyer K, Anwar M, Rodriguez E, Patel S, Rodino K, Glaser L, Richterman A. Delayed diagnosis of disseminated Mycobacterium intracellulare subsp. chimaera infective endocarditis via cell-free metagenomic next-generation sequencing: a case report , ASM Case Rep, 1: 2025,e00003-25
Kreider EF, Ortega-Burgos Y, Dumeng-Rodriguez J, Gesualdi J, O'Brien C, Bracy D, Johnson J, Bowman J, Metzger D, Dine CJ, Favor K, Jordan-Sciutto KL, Momplaisir F. Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS Workforce , J Acquir Immune Defic Syndr, 94(25): 2023,S28-S35
Kreider EF, Bar KJ. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies , Curr HIV/AIDS Rep, 19(3): 2022,194-206
Bricault CA, Yusim K, Seaman MS, Yoon H, Theiler J, Giorgi EE, Wagh K, Theiler M, Hraber P, Macke JP, Kreider EF, Learn GH, Hahn BH, Scheid JF, Kovacs JM, Shields JL, Lavine CL, Ghantous F, Rist M, Bayne MG, Neubauer GH, McMahan K, Peng H, Chéneau C, Jones JJ, Zeng J, Ochsenbauer C, Nkolola JP, Stephenson KE, Chen B, Gnanakaran S, Bonsignori M, Williams LD, Haynes BF, Doria-Rose N, Mascola JR, Montefiori DC, Barouch DH, Korber B. HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design , Cell Host Microbe, 26(2): 2019,296